​

Third Harmonic Bio Ownership | Who Owns Third Harmonic Bio?

OverviewForecastRevenueFinancialsChart

Third Harmonic Bio Ownership Summary

Third Harmonic Bio is owned by 106.56% institutional investors, 9.05% insiders. Atlas venture life science advisors is the largest institutional shareholder, holding 26.90% of THRD shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 2.06% of its assets in Third Harmonic Bio shares.

THRD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockThird Harmonic Bio106.56%9.05%-15.61%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Atlas venture life science advisors10.91M26.90%$141.80M
Orbimed advisors5.78M14.25%$75.13M
Bvf inc/il4.37M10.77%$56.76M
Ecor1 capital3.18M7.85%$41.37M
General atlantic2.96M7.30%$38.46M
Ra capital management2.03M5.01%$26.43M
Boxer capital2.00M4.93%$26.00M
Commodore capital lp1.55M3.81%$20.09M
Blackrock1.43M3.55%$18.56M
T. rowe price investment management1.35M3.33%$17.54M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Atlas venture life science advisors10.91M14.93%$141.80M
Bvf inc/il4.37M1.59%$56.76M
Orbimed advisors5.78M1.49%$75.13M
Commodore capital lp1.55M1.37%$20.09M
Boxer capital2.00M1.37%$26.00M
Ecor1 capital3.18M1.27%$41.37M
General atlantic2.96M1.21%$38.46M
Ra capital management2.03M0.35%$26.43M
Parkman healthcare partners133.32K0.23%$1.73M
Ubs oconnor49.25K0.04%$640.26K

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management1.35M0.01%1.35M
Commodore capital lp1.55M1.37%295.43K
Invesco270.99K0.00%270.99K
Schonfeld strategic advisors330.25K0.03%120.75K
Parkman healthcare partners133.32K0.23%93.33K

Top Sellers

HolderShares% AssetsChange
Jpmorgan chase13.44K--428.70K
Sio capital management---163.36K
Millennium management101.93K0.00%-153.37K
Bridgeway capital management---45.00K
Squarepoint ops---32.18K

New Positions

HolderShares% AssetsChangeValue
T. rowe price investment management1.35M0.01%1.35M$17.54M
State of wisconsin investment board26.21K0.00%26.21K$340.76K
Kingswood wealth advisors18.90K0.02%18.90K$245.70K
Franklin resources17.23K0.00%17.23K$223.96K
Dimensional fund advisors lp14.47K-14.47K$188.08K

Sold Out

HolderChange
Covestor-251.00
Metropolitan life insurance co/ny-1.25K
American group-9.60K
Cibc asset management-10.57K
Occudo quantitative strategies lp-14.22K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20248513.33%44,027,8929.42%1061.08%508.70%1820.00%
Jun 30, 2024758.70%40,236,4216.25%991.12%4635.29%15-16.67%
Mar 31, 20246913.11%37,870,562-0.13%941.04%34-15.00%1838.46%
Dec 31, 20236110.91%37,920,1350.34%941.05%4033.33%1318.18%
Sep 30, 20235519.57%37,791,4254.80%951.15%30-11266.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price Small-Cap Value846.79K2.06%-26.09K
T. Rowe Price Small-Cap Stock564.62K1.37%564.62K
T. Rowe Price US Small-Cap Core Equity564.62K1.37%564.62K
Vanguard Total Stock Mkt Idx Inv517.12K1.16%-
iShares Russell 2000 ETF514.59K1.15%-1.16K
T. Rowe Price U.S. SC Value Eq Tr-Z443.05K1.08%850.00
T. Rowe Price Instl Small-Cap Stock280.06K0.68%280.06K
T. Rowe Price U.S. SC Core Eq Tr-Z279.97K0.68%279.97K
Fidelity Advisor Biotechnology I265.15K0.65%265.15K
Invesco Dorsey Wright SmallCap Momt ETF261.65K0.64%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 08, 2024Conner Edward R. Chief Medical OfficerSell$31.75K
Oct 29, 2024BVF PARTNERS L P/IL See Explanation of ResponsesSell$5.68M
Oct 29, 2024BVF PARTNERS L P/IL See Explanation of ResponsesSell$7.70M
Oct 29, 2024BVF PARTNERS L P/IL See Explanation of ResponsesSell$924.02K
Oct 28, 2024Conner Edward R. Chief Medical OfficerSell$40.09K

Insider Transactions Trends

DateBuySell
2024 Q4-4
2024 Q3-3
2024 Q2-7
2024 Q1--
2023 Q4-2

THRD Ownership FAQ

Who Owns Third Harmonic Bio?

Third Harmonic Bio shareholders are primarily institutional investors at 106.56%, followed by 9.05% insiders and -15.61% retail investors. The average institutional ownership in Third Harmonic Bio's industry, Biotech Stocks , is 47.04%, which Third Harmonic Bio exceeds.

Who owns the most shares of Third Harmonic Bio?

Third Harmonic Bio’s largest shareholders are Atlas venture life science advisors (10.91M shares, 26.90%), Orbimed advisors (5.78M shares, 14.25%), and Bvf inc/il (4.37M shares, 10.77%). Together, they hold 51.91% of Third Harmonic Bio’s total shares outstanding.

Does Blackrock own Third Harmonic Bio?

Yes, BlackRock owns 3.55% of Third Harmonic Bio, totaling 1.43M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 18.56M$. In the last quarter, BlackRock increased its holdings by 65.78K shares, a 4.83% change.

Who is Third Harmonic Bio’s biggest shareholder by percentage of total assets invested?

Atlas venture life science advisors is Third Harmonic Bio’s biggest shareholder by percentage of total assets invested, with 14.93% of its assets in 10.91M Third Harmonic Bio shares, valued at 141.8M$.

Who is the top mutual fund holder of Third Harmonic Bio shares?

T. Rowe Price Small-Cap Value is the top mutual fund holder of Third Harmonic Bio shares, with 2.06% of its total shares outstanding invested in 846.79K Third Harmonic Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools